Amedeo's Top 20

Amedeo Smart

Independent Medical Education

28 March 2022

Multidisciplinary Journal Club

  1. Finfer S, Micallef S, Hammond N, Navarra L, et al.
    Balanced Multielectrolyte Solution versus Saline in Critically Ill Adults.
    N Engl J Med 2022;386:815-826.

  1. Finfer S, Micallef S, Hammond N, Navarra L, et al.
    Balanced Multielectrolyte Solution versus Saline in Critically Ill Adults.
    N Engl J Med 2022;386:815-826.

  2. Reid IR, Billington EO.
    Drug therapy for osteoporosis in older adults.
    Lancet 2022;399:1080-1092.

  3. Reid IR, Billington EO.
    Drug therapy for osteoporosis in older adults.
    Lancet 2022;399:1080-1092.

  4. Weiss RA, Wain-Hobson S.
    Luc Montagnier (1932-2022).
    Science 2022;375:1235.

  1. Weiss RA, Wain-Hobson S.
    Luc Montagnier (1932-2022).
    Science 2022;375:1235.

  2. .
    EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis.
    J Hepatol 2022.

  3. .
    EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis.
    J Hepatol 2022.

  4. Tilki D, Chen MH, Wu J, Huland H, et al.
    Adjuvant Versus Early Salvage Radiation Therapy After Radical Prostatectomy for pN1 Prostate Cancer and the Risk of Death.
    J Clin Oncol 2022.

  5. Tilki D, Chen MH, Wu J, Huland H, et al.
    Adjuvant Versus Early Salvage Radiation Therapy After Radical Prostatectomy for pN1 Prostate Cancer and the Risk of Death.
    J Clin Oncol 2022.

  1. Bath PM, Song L, Silva GS, Mistry E, et al.
    Blood Pressure Management for Ischemic Stroke in the First 24 Hours.
    Stroke 2022.

  2. Bath PM, Song L, Silva GS, Mistry E, et al.
    Blood Pressure Management for Ischemic Stroke in the First 24 Hours.
    Stroke 2022.

  3. Marcucci M, Etxeandia-Ikobaltzeta I, Yang S, Germini F, et al.
    Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials.
    BMJ 2022;376:e066785.

  4. Marcucci M, Etxeandia-Ikobaltzeta I, Yang S, Germini F, et al.
    Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials.
    BMJ 2022;376:e066785.

  5. Kister I, Patskovsky Y, Curtin R, Pei J, et al.
    Cellular and humoral immunity to SARS-CoV-2 infection in multiple sclerosis patients on ocrelizumab and other disease-modifying therapies: a multi-ethnic observational study.
    Ann Neurol 2022.

  1. Kister I, Patskovsky Y, Curtin R, Pei J, et al.
    Cellular and humoral immunity to SARS-CoV-2 infection in multiple sclerosis patients on ocrelizumab and other disease-modifying therapies: a multi-ethnic observational study.
    Ann Neurol 2022.

  2. Shadman M, Pasquini M, Ahn KW, Chen Y, et al.
    Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission.
    Blood 2022;139:1330-1339.

  3. Shadman M, Pasquini M, Ahn KW, Chen Y, et al.
    Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission.
    Blood 2022;139:1330-1339.

  4. Langer-Gould A, Cheng SC, Li BH, Smith JB, et al.
    Decreasing Multiple Sclerosis Treatment Expenditures and Improving Quality at the Health System Level.
    Ann Neurol 2022.

  5. Langer-Gould A, Cheng SC, Li BH, Smith JB, et al.
    Decreasing Multiple Sclerosis Treatment Expenditures and Improving Quality at the Health System Level.
    Ann Neurol 2022.


more..

Privacy Policy